Healthcare provider profile · identity verified

Leticia Cobos, PHYSICIAN ASSISTANT

Physician Assistant · MISSION, TX · NPI 1508282708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	967	306
Lisinopril	Lisinopril	391	135
Levothyroxine Sodium	Levothyroxine Sodium	365	135
Telmisartan	Telmisartan	316	103
Amlodipine Besylate	Amlodipine Besylate	314	102
Metoprolol Succinate	Metoprolol Succinate	268	97
Metformin Hcl	Metformin Hcl	256	87
Jardiance	Empagliflozin	225	71
Tamsulosin Hcl	Tamsulosin Hcl	222	86
Gabapentin	Gabapentin	208	110
Sertraline Hcl	Sertraline Hcl	195	77
Rosuvastatin Calcium	Rosuvastatin Calcium	179	59
Prednisone	Prednisone	164	134
Azithromycin	Azithromycin	163	136
Furosemide	Furosemide	152	54
Ozempic	Semaglutide	152	40
Duloxetine Hcl	Duloxetine Hcl	150	70
Tramadol Hcl	Tramadol Hcl	148	47
Losartan Potassium	Losartan Potassium	131	42
Donepezil Hcl	Donepezil Hcl	127	52
Pioglitazone Hcl	Pioglitazone Hcl	126	42
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	119	32
Famotidine	Famotidine	112	63
Ipratropium Bromide	Ipratropium Bromide	111	82
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	109	58
Memantine Hcl	Memantine Hcl	104	33
Glimepiride	Glimepiride	101	37
Carvedilol	Carvedilol	97	29
Buspirone Hcl	Buspirone Hcl	94	38
Ezetimibe	Ezetimibe	90	32
Finasteride	Finasteride	90	30
Myrbetriq	Mirabegron	90	28
Hydralazine Hcl	Hydralazine Hcl	84	28
Montelukast Sodium	Montelukast Sodium	82	37
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	81	24
Metformin Hcl Er	Metformin Hcl	80	28
Omeprazole	Omeprazole	78	42
Quetiapine Fumarate	Quetiapine Fumarate	77	26
Hydrochlorothiazide	Hydrochlorothiazide	76	29
Cefdinir	Cefdinir	73	61
Meclizine Hcl	Meclizine Hcl	69	49
Fluticasone Propionate	Fluticasone Propionate	66	35
Dutasteride	Dutasteride	62	22
Tradjenta	Linagliptin	62	15
Metoprolol Tartrate	Metoprolol Tartrate	60	24
Celecoxib	Celecoxib	59	51
Clopidogrel	Clopidogrel Bisulfate	57	27
Gemtesa	Vibegron	55	20
Baclofen	Baclofen	54	45
Pantoprazole Sodium	Pantoprazole Sodium	54	27
Doxazosin Mesylate	Doxazosin Mesylate	52	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	52	43
Fenofibrate	Fenofibrate Nanocrystallized	50	19
Januvia	Sitagliptin Phosphate	50	13
Meloxicam	Meloxicam	50	38
Trazodone Hcl	Trazodone Hcl	50	29
Eliquis	Apixaban	49	18
Mirtazapine	Mirtazapine	48	22
Nebivolol Hcl	Nebivolol Hcl	48	15
Pravastatin Sodium	Pravastatin Sodium	45	14
Linzess	Linaclotide	44	22
Pregabalin	Pregabalin	42	suppressed
Trulicity	Dulaglutide	42	15
Spironolactone	Spironolactone	41	16
Olmesartan Medoxomil	Olmesartan Medoxomil	38	16
Vascepa	Icosapent Ethyl	38	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	36
Icosapent Ethyl	Icosapent Ethyl	33	15
Primidone	Primidone	33	14
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Enalapril Maleate	Enalapril Maleate	32	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	16
Xarelto	Rivaroxaban	32	14
Atenolol	Atenolol	31	suppressed
Tresiba Flextouch U-100	Insulin Degludec	31	suppressed
Nifedipine Er	Nifedipine	30	11
Nystatin	Nystatin	30	14
Cholestyramine	Cholestyramine (With Sugar)	28	21
Vraylar	Cariprazine Hcl	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	16
Prolia	Denosumab	27	22
Glipizide	Glipizide	25	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	24	suppressed
Cefuroxime	Cefuroxime Axetil	23	17
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	21
Fluconazole	Fluconazole	22	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	11
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Clotrimazole	Clotrimazole	21	17
Glipizide Er	Glipizide	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Xifaxan	Rifaximin	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Doxycycline Monohydrate	Doxycycline Monohydrate	19	18
Albuterol Sulfate Hfa	Albuterol Sulfate	18	13
Cilostazol	Cilostazol	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	12
Bumetanide	Bumetanide	17	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Veltassa	Patiromer Calcium Sorbitex	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Metronidazole	Metronidazole	13	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Testosterone	Testosterone	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Digoxin	Digoxin	11	suppressed
Hydrocortisone	Hydrocortisone	11	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error